Nasodren
Natural health product licensed in Canada
- Licence holder
- Averroes Trading Canada Inc.
- NPN or DIN-HM
- 80114318
- Status
- Inactive licence
- Licence date
- 18 November 2021
- Revision date
- Not provided
- Form
- Pulvérisateur, à dose mesurée
- Route of administration
- Nasale
- Application type
- Homéopathique (non officinale)
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants et Adolescents | minimum: 5 years ; maximum: 18 years | 0.13 mL | 1 Tous les jours |
| Adultes | minimum: 18 years | 0.13 mL | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Drain mucus and clears the nose and sinuses. NASODREN is indicated for the treatment of Acute and Chronic Rhinosinusitis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80114318
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.